Loading...
Market
Which extinct species will Colossal Biosciences successfully clone by the end of 2025?
2
Resolution / Starting Odds
Woolly Mammoth • 25%
Tasmanian Tiger • 25%
Dodo Bird • 25%
Other • 25%
Official announcement by Colossal Biosciences or reputable scientific publications
Story
Colossal Biosciences Secures $200M in Series C Funding from TWG Global, Valued at $10.2B for De-Extinction
Jan 15, 2025, 02:35 PM
Colossal Biosciences, a Dallas-based startup focused on de-extinction, has raised $200 million in a Series C funding round led by TWG Global, a holding company jointly led by Mark Walter and Thomas Tull. This brings the company's total funding to $435 million since its launch in 2021, and its valuation now stands at $10.2 billion. Colossal aims to bring back extinct species such as the woolly mammoth, the Tasmanian tiger, and the dodo bird. The new funds will be used to advance genetic engineering technologies and expand the company's de-extinction species list, while also supporting conservation efforts through the Colossal Foundation, which currently supports 48 conservation partners worldwide.
View original story
Similar markets
Passenger Pigeon • 25%
Moa • 25%
Other • 25%
Saber-toothed Tiger • 25%
Other • 25%
Thylacine • 25%
Dodo Bird • 25%
Woolly Mammoth • 25%
1 new species • 25%
More than 3 new species • 25%
3 new species • 25%
2 new species • 25%
Other • 25%
Conservation International • 25%
WWF • 25%
The Nature Conservancy • 25%
Megalosaurus • 25%
Cetiosaurus • 25%
Other known species • 25%
Newly identified species • 25%
New theropod species • 25%
New sauropod species • 25%
Both sauropod and theropod • 25%
No new species • 25%
